In addition to the role of HDAC inhibitors in sensitizing tumor cells to chemoradiotherapy, studies have also investigated the role of HDAC inhibitors in regulating immune-related genes, such as CD40 expression and HLA class I and II in different cancer cell lines [34,35,36]. This evidence concerns the gene HDAC9 and neoplasm.